2011 年的透析：能否降低透析患者的心血管风险？
Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased?
机构信息
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital at Huddinge, Karolinska Institutet, SE 141 86 Stockholm, Sweden.
出版信息
Nat Rev Nephrol. 2011 Dec 13;8(2):72-4. doi: 10.1038/nrneph.2011.212.
PMID:22158474
Abstract
More than 1.4 million patients are on renal replacement therapy worldwide. Mortality in patients with end-stage renal disease (ESRD) is as high as that seen in some types of metastatic cancer, and premature cardiovascular disease is the major killer in ESRD. Several publications in 2011 addressed how interventions can modify cardiovascular risk factors and improve outcomes.
摘要
全球有超过 140 万名患者接受肾脏替代治疗。终末期肾病（ESRD）患者的死亡率与某些类型的转移性癌症相当，而心血管疾病是 ESRD 的主要死因。2011 年的几项研究探讨了干预措施如何改变心血管风险因素并改善预后。
Zotero 插件